Sodium intake combining cholinergic activation and noradrenaline into the lateral parabrachial nucleus

Highlights • Different mechanisms inhibit sodium intake in rats treated with cholinergic agonists. • Pressor responses inhibit sodium intake in rats treated with cholinergic agonists. • Noradrenaline in the LPBN deactivates inhibitory mechanisms for sodium intake. • Noradrenaline in the LPBN does no...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Neuroscience 2015-08, Vol.300, p.229-237
Hauptverfasser:	Gasparini, S, Andrade-Franzé, G.M.F, Gomide, J.M.C, Andrade, C.A.F, De Luca, L.A, Colombari, D.S.A, De Paula, P.M, Colombari, E, Menani, J.V
Format:	Artikel
Sprache:	eng
Schlagworte:	Animals Antihypertensive Agents - pharmacology baro and volume receptors blood pressure Blood Pressure - drug effects Blood Pressure - physiology Carbachol - pharmacology Catheters, Indwelling Cholinergic Agonists - pharmacology Drinking - drug effects Drinking - physiology Heart Rate - drug effects Heart Rate - physiology Male Neurology Norepinephrine - metabolism parabrachial nucleus Parabrachial Nucleus - drug effects Parabrachial Nucleus - metabolism Pilocarpine - pharmacology Prazosin - pharmacology Rats, Sprague-Dawley sodium appetite Sodium Chloride, Dietary α2 adrenoceptors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Highlights • Different mechanisms inhibit sodium intake in rats treated with cholinergic agonists. • Pressor responses inhibit sodium intake in rats treated with cholinergic agonists. • Noradrenaline in the LPBN deactivates inhibitory mechanisms for sodium intake. • Noradrenaline in the LPBN does not deactivate cardiovascular inhibitory signals.
ISSN:	0306-4522 1873-7544
DOI:	10.1016/j.neuroscience.2015.04.059